A long-term study has confirmed the durability of benefits and safety of a newly FDA-approved drug to treat excessive daytime sleepiness due to narcolepsy or obstructive sleep apnea.
The international ADHERE registry of real-world use of hypoglossal nerve stimulation also showed a nonsignificant trend toward better outcomes in women than in men.
Alan Kominsky, MD, Section Head of Surgical Sleep and Snoring in Cleveland Clinic’s Head & Neck Institute, says hypoglossal nerve stimulation is changing the surgical paradigm for OSA. Here’s why.
A new study shows adults over 60 with sleep apnea achieve improvements in sleepiness, fatigue, depression and quality of life comparable to those in their younger counterparts.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Findings from a large neurological outpatient sample raise the prospect of studying sleep therapies for their effect on disease-specific outcomes in a range of neurological conditions.
An innovative group-therapy approach to promoting PAP treatment adherence is proving its worth as outcomes data mount.
Cleveland Clinic has started screening all patients with epilepsy for obstructive sleep apnea — and treating them with PAP if they test positive. Findings from this newly presented study explain why.
The directors of Cleveland Clinic’s Sleep Disorders Center and Sleep Research Center break down the new USPSTF report.
The nation’s leading sleep medicine society has updated guidelines on testing for sleep apnea for the first time in 10 years. A co-author of the document outlines key changes in recommendations.
Patients with neuromuscular disease are at greater risk of sleep-disordered breathing and require evaluation and treatment in a multidisciplinary clinic.